Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies
| Title: | Ruxolitinib Cream As-Needed Monotherapy Demonstrates Sustained Disease and Symptom Control in Patients with Mild to Moderate Atopic Dermatitis: Pooled Analysis from Two Phase 3 Studies |
|---|---|
| Authors: | Blauvelt, AndrewAff1, Aff2; Kircik, LeonAff3, Aff4; Simpson, Eric L.Aff5; Lio, PeterAff6; Eichenfield, Lawrence F.Aff7; Prajapati, Vimal H.Aff8, Aff9, Aff10, Aff11, Aff12, Aff13; Grewal, ParbeerAff14; Lynde, CharlesAff15, Aff16; Hong, H. Chih-hoAff17, Aff18; Sturm, DanielAff19; Kallender, HowardAff19; Ren, HaoboAff19; Paranagama, DilanAff19; Wong, Grace K. W.Aff20; Geng, BobAff7, IDs13555025016390_cor1 |
| Source: | Dermatology and Therapy: Research, treatment and aesthetic interventions in dermatology. 16(3):1635-1646 |
| Database: | Springer Nature Journals |